Skip to main content
International Journal of Clinical and Experimental Pathology logoLink to International Journal of Clinical and Experimental Pathology
. 2015 Apr 1;8(4):4242–4247.

Articular nodular fasciitis of the right shoulder joint: report of an unusual case with focus on immunohistochemical differential diagnosis

Shogo Tajima 1,2, Tomoyukisu Zuki 2, Kenji Koda 3
PMCID: PMC4467006  PMID: 26097619

Abstract

The mesenchymal lesion nodular fasciitis (NF) can affect various sites of the body but usually arises in subcutaneous tissue or occasionally skeletal muscle. NF is not commonly known to arise in joints, and articular NF is extremely rare. Herein, we present a case of a 54-year-old woman with articular NF. No sign of recurrence was observed after surgical piecemeal removal with a suspected positive surgical margin. In our case, a differential diagnosis of NF, desmoid-type fibromatosis, and low-grade myofibroblastic sarcoma was considered. Stromal hyalinization, a characteristic of articular NF, made the diagnosis somewhat difficult, although typical NF morphology was present. Immunohistochemical analysis of α-smooth muscle actin, desmin, β-catenin, and protein gene product 9.5 expression along with close morphological examination provided a reliable distinction.

Keywords: Articular nodular fasciitis, shoulder joint, immunohistochemistry

Introduction

Nodular fasciitis (NF) is a type of mesenchymal lesion that can affect various sites of the body, although it usually arises in subcutaneous tissue or occasionally in skeletal muscle [1-4]. NF is not commonly known to arise in joints, and articular NF is extremely rare [5,6]. Clinically, NF is characterized by a rapidly (few weeks’ duration) growing subcutaneous mass that may exhibit spontaneous regression [1-4]. Histologically, NF occasionally mimics sarcoma because of its high cellularity and mitotic rate, possibly leading to an inappropriate diagnosis [7].

Recently, approximately 90% of NFs were found to harbor rearrangements of the USP6 gene, and the novel MYH9-USP6 fusion accounted for two thirds of these rearrangements [8]. Although rearrangements of the USP6 gene can be detected using fluorescence in situ hybridization or reverse transcription-polymerase chain reaction, these techniques cannot be easily applied in routine pathological practice. An immunohistochemical method for differentiating between NF and its mimics should be first considered.

Herein, we present the case of a 54-year-old woman with articular NF and an immunohistochemical approach for differentiating articular NF from its morphological mimics such as desmoid-type fibromatosis (DF) [9] and low-grade myofibroblastic sarcoma (LGMS) [10].

Clinical summary

A 54-year-old Japanese woman visited an outpatient clinic because of a lump on the ventral side of her right shoulder that was causing shoulder pain and decreased range of motion. The patient reported that she had not noticed the mass on her shoulder until approximately 2 months before presentation. Soon after detection, she noticed that the mass increased in size and began to feel right shoulder pain; she reported no fever, fatigue, numbness, or other specific complaints. During a physical examination, a 5-cm x 6-cm solid mass without mobility or tenderness was found on the ventral side of her right shoulder. The range of shoulder joint motion, including flexion, abduction, and external rotation, was limited. X-ray of the right shoulder did not find any abnormality. Magnetic resonance imaging revealed an irregularly shaped mass at the right shoulder joint. The articular mass exhibited relatively low signal intensity on T1-weighted images (Figure 1A), high signal intensity on T2-weighted images (Figure 1B), and pronounced high signal intensity on T2-weighted fat-suppressed images (Figure 1C). Contrast enhancement was observed on T1-weighted fat-suppressed images (Figure 1D). The patient was subsequently hospitalized. Shoulder arthroscopy was performed and the soft-tissue mass was resected in a piecemeal manner. Her postoperative course was uneventful, and she recovered shoulder joint motion. She has remained recurrence-free for 3 months.

Figure 1.

Figure 1

Magnetic resonance imaging of the mass at the right shoulder joint. A. T1-weighted imaging showed low signal intensity. B. T2-weighted imaging revealed high signal intensity. C. T2-weighted fat-suppressed imaging displayed pronounced high signal intensity. D. Contrast enhancement was observed with T1-weighted fat-suppressed imaging.

Pathological findings

The surgical specimens were removed in a piecemeal manner. Given the method of lesion removal, the surgical margin was considered to be positive.

In fact, microscopically, nearly the entire areas of all specimens contained lesional cells, and remaining lesional cells were suspected. Lesional cells were observed to proliferate haphazardly or form fascicles within a myxoid background, accompanied by focal areas of extravasated red blood cells; inflammatory cell infiltration was modest (Figure 2A). The lesional cells exhibited a spindle shape with weakly eosinophilic cytoplasm and presented focally in a tissue-culture-like growth pattern; their nuclei exhibited mild enlargement without obvious atypia (Figure 2A, inset). Two mitotic figures per 10 high-power fields were detected in the most affected area. In some areas, older changes accompanied by the deposition of collagen fibers (Figure 2B) were observed along with the oldest part of the lesion, which contained abundant hyalinized collagen fibers (Figure 2C).

Figure 2.

Figure 2

Microscopic findings. A. Lesional cells were observed to proliferate haphazardly or form fascicles within a myxoid background, accompanied by focal areas of extravasated red blood cells; inflammatory cell infiltration was modest (40× magnification). Inset: lesional cells were spindle-shaped with weakly eosinophilic cytoplasm and focally presented a tissue-culture-like growth pattern; nuclei exhibited mild enlargement without obvious atypia (600×). B. Older changes accompanied by collagen fiber deposition were observed (200×). C. The oldest part of the lesion contained abundant hyalinized collagen fibers (200×).

Immunohistochemistry (IHC) revealed that the spindle cells were positive for α-smooth muscle actin (SMA; 1A4, 1:100; Dako, Glostrup, Denmark) (Figure 3A) and negative for desmin (D33, 1:100; Dako) (data not shown). β-catenin (β-Catenin-1, 1:100; Dako) positivity was observed in the cytoplasm but not in the nuclei (Figure 3B). Protein gene product (PGP) 9.5 (13C4, 1:50; Abcam, Cambridge, UK) expression was observed in the spindle cells (Figure 3C). A stain for anaplastic lymphoma kinase 1 (ALK1, 1:25; Dako) was negative (data not shown).

Figure 3.

Figure 3

Immunohistochemical findings. A. Positivity for α-smooth muscle actin (400× magnification). B. Positivity for β-catenin was observed in the cytoplasm but not in the nuclei (400×). C. Positivity for protein gene product 9.5 (400×). D. Positivity for matrix metalloprotease 3 (400×).

A diagnosis of articular NF was rendered after considering the IHC results together with the morphological findings.

After making the diagnosis, additional IHC using matrix metalloprotease 3 (EP1186Y, 1:100; Epitomics, Burlingame, CA) was performed and spindle cells were positive for it (Figure 3D).

Discussion

The differential diagnosis of articular NF in the shoulder joint included two types of lesions: spindle cell lesions occurring near the joint and lesions with close morphological similarity to NF, which is not usually seen near the joint. Examples of the former type include fibroma of the tendon sheath [11] and juxta-articular myxoma [12]. Examples of the latter type include DF [9], LGMS [10], and inflammatory myofibroblastic tumor [13]. As fibroma of the tendon sheath nearly always occurs in the hands [11] and juxta-articular myxoma nearly always occurs in the knee [12], both of these lesions could be almost excluded. Given the modest inflammatory background along with ALK negativity, this case did not match the definition of an inflammatory myofibroblastic tumor [13,14]. The remaining differential diagnosis included DF and LGMS. The typical IHC patterns of NF, DF, and LGMS are summarized in Table 1; αSMA expression is common feature among all three lesions [10,15]. DF usually presents as proliferating spindle cells on a collagenous background with nuclear β-catenin expression; the myxoid background observed in this case is not usually encountered except for cases in the mesentery [5,9,16,17]. DF usually does not express desmin, similar to NF [15]. One noticeable characteristic of articular NF in this case that introduced possible confusion regarding DF was stromal hyalinization, which could be attributed to the longer clinical history prior to surgery when compared to NF at other sites (history range of articular NF: 2 months to 1 year) [5]. LGMS usually comprises spindle cells with more hyperchromatic nuclei and higher cellularity than NF, and LGMS lesions tend to express αSMA and desmin [10]. Unlike NF, some cases of LGMS may unexpectedly express nuclear β-catenin [17]. Last but not least, PGP9.5, a known neuron- and neuroendocrine-specific ubiquitin carboxyl terminal hydrolase, is expressed in NF [18] and other mesenchymal tumors, although this expression is possibly aberrant [19]; no reliable data is available for DF and LGMS.

Table 1.

Typical immunohistochemical characteristics of nodular fasciitis (NF), desmoid-type fibromatosis (DF), and low-grade myofibroblastic sarcoma (LGMS)

αSMA Desmin nuclear β-catenin PGP 9.5
NF + - - +
DF + - + NA
LGMS + + - NA

NA: reliable data is not available.

From a genetic viewpoint, an important difference between NF and DF involves the expression pattern of genes related to inflammation and remodeling of the extracellular matrix. NF is associated with a more elevated expression of genes encoding proteases that participate in extracellular matrix degradation, such as matrix metalloprotease 1, 3, 9, and 13 [20]. Recently, approximately 90% of NFs were found to harbor rearrangements of the USP6 gene [8]; USP6 protein participates in inflammatory signaling and induces the expression of matrix metalloproteases through the activation of NF-κB, a transcription factor involved in inflammation [21]. In contrast, DF exhibits increased expression of genes encoding members of the TGF-β signaling pathway [20]. TGF-β promotes fibroblast/myofibroblast proliferation and extracellular matrix protein synthesis [22,23]. These signaling pathway differences between NF and DF could explain the respective myxoid and collagenous backgrounds typical of these lesions.

Articular NF tends not to recur, although the number of cases has been limited [5]. In our case, the surgical margin was considered positive, but no sign of recurrence was observed. However, careful follow-up is still required because of the lack of proof regarding the biological nature of articular NF.

In conclusion, we have presented an extremely rare case of articular NF. In contrast to DF, USP6 gene rearrangement leads to matrix metalloprotease upregulation and extracellular matrix degradation in NF. However, articular NF in particular tends to exhibit stromal hyalinization in addition to typical morphological features, thus rendering differential diagnosis somewhat difficult. For this differential diagnosis, IHC was a useful ancillary method along with close morphological examination.

Disclosure of conflict of interest

None.

References

  • 1.Bernstein KE, Lattes R. Nodular (pseudosarcomatous) fasciitis, a nonrecurrent lesion: clinicopathologic study of 134 cases. Cancer. 1982;49:1668–1678. doi: 10.1002/1097-0142(19820415)49:8<1668::aid-cncr2820490823>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  • 2.Shimizu S, Hashimoto H, Enjoji M. Nodular fasciitis: an analysis of 250 patients. Pathology. 1984;16:161–166. doi: 10.3109/00313028409059097. [DOI] [PubMed] [Google Scholar]
  • 3.Meister P, Buckmann FW, Konrad E. Nodular fasciitis (analysis of 100 cases and review of the literature) Pathol Res Pract. 1978;162:133–165. doi: 10.1016/S0344-0338(78)80001-6. [DOI] [PubMed] [Google Scholar]
  • 4.Price EB Jr, Silliphant WM, Shuman R. Nodular fasciitis: a clinicopathologic analysis of 65 cases. Am J Clin Pathol. 1961;35:122–136. doi: 10.1093/ajcp/35.2.122. [DOI] [PubMed] [Google Scholar]
  • 5.Hornick JL, Fletcher CD. Intraarticular nodular fasciitis--a rare lesion: clinicopathologic analysis of a series. Am J Surg Pathol. 2006;30:237–241. doi: 10.1097/01.pas.0000180441.48904.50. [DOI] [PubMed] [Google Scholar]
  • 6.Harish S, Kuruvilla M, Alowami S, DeNardi F, Ghert M. Intra-articular nodular fasciitis of the shoulder: a case report and review of the literature. Skeletal Radiol. 2011;40:1383–1386. doi: 10.1007/s00256-011-1182-7. [DOI] [PubMed] [Google Scholar]
  • 7.Tomita S, Thompson K, Carver T, Vazquez WD. Nodular fasciitis: a sarcomatous impersonator. J Pediatr Surg. 2009;44:e17–19. doi: 10.1016/j.jpedsurg.2009.01.047. [DOI] [PubMed] [Google Scholar]
  • 8.Erickson-Johnson MR, Chou MM, Evers BR, Roth CW, Seys AR, Jin L, Ye Y, Lau AW, Wang X, Oliveira AM. Nodular fasciitis: a novel model of transient neoplasia induced by MYH9-USP6 gene fusion. Lab Invest. 2011;91:1427–1433. doi: 10.1038/labinvest.2011.118. [DOI] [PubMed] [Google Scholar]
  • 9.Grobmyer SR, Knapik JA, Foss RM, Copeland EM, Hochwald SN. Nodular fasciitis: differential considerations and current management strategies. Am Surg. 2009;75:610–614. [PubMed] [Google Scholar]
  • 10.Mentzel T, Dry S, Katenkamp D, Fletcher CD. Low-grade myofibroblastic sarcoma: analysis of 18 cases in the spectrum of myofibroblastic tumors. Am J Surg Pathol. 1998;22:1228–1238. doi: 10.1097/00000478-199810000-00008. [DOI] [PubMed] [Google Scholar]
  • 11.Pulitzer DR, Martin PC, Reed RJ. Fibroma of tendon sheath. A clinicopathologic study of 32 cases. Am J Surg Pathol. 1989;13:472–479. doi: 10.1097/00000478-198906000-00003. [DOI] [PubMed] [Google Scholar]
  • 12.Meis JM, Enzinger FM. Juxta-articular myxoma: a clinical and pathologic study of 65 cases. Hum Pathol. 1992;23:639–646. doi: 10.1016/0046-8177(92)90319-x. [DOI] [PubMed] [Google Scholar]
  • 13.Qiu X, Montgomery E, Sun B. Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts. Hum Pathol. 2008;39:846–856. doi: 10.1016/j.humpath.2007.10.010. [DOI] [PubMed] [Google Scholar]
  • 14.Coffin CM, Patel A, Perkins S, Elenitoba-Johnson KS, Perlman E, Griffin CA. ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor. Mod Pathol. 2001;14:569–576. doi: 10.1038/modpathol.3880352. [DOI] [PubMed] [Google Scholar]
  • 15.Hasegawa T, Hirose T, Kudo E, Abe J, Hizawa K. Cytoskeletal characteristics of myofibroblasts in benign neoplastic and reactive fibroblastic lesions. Virchows Arch A Pathol Anat Histopathol. 1990;416:375–382. doi: 10.1007/BF01605141. [DOI] [PubMed] [Google Scholar]
  • 16.Bhattacharya B, Dilworth HP, Iacobuzio-Donahue C, Ricci F, Weber K, Furlong MA, Fisher C, Montgomery E. Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions. Am J Surg Pathol. 2005;29:653–659. doi: 10.1097/01.pas.0000157938.95785.da. [DOI] [PubMed] [Google Scholar]
  • 17.Carlson JW, Fletcher CD. Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature. Histopathology. 2007;51:509–514. doi: 10.1111/j.1365-2559.2007.02794.x. [DOI] [PubMed] [Google Scholar]
  • 18.Morgen EK, Carter P, Weinreb I, Al-Habeeb A, Ghazarian DM. Immunohistochemistry in nodular fasciitis of the head and neck. Pathology. 2013;45:432–433. doi: 10.1097/PAT.0b013e328360f06a. [DOI] [PubMed] [Google Scholar]
  • 19.Campbell LK, Thomas JR, Lamps LW, Smoller BR, Folpe AL. Protein gene product 9.5 (PGP 9.5) is not a specific marker of neural and nerve sheath tumors: an immunohistochemical study of 95 mesenchymal neoplasms. Mod Pathol. 2003;16:963–969. doi: 10.1097/01.MP.0000087088.88280.B0. [DOI] [PubMed] [Google Scholar]
  • 20.Bacac M, Migliavacca E, Stehle JC, McKee T, Delorenzi M, Coindre JM, Guillou L, Stamenkovic I. A gene expression signature that distinguishes desmoid tumours from nodular fasciitis. J Pathol. 2006;208:543–553. doi: 10.1002/path.1915. [DOI] [PubMed] [Google Scholar]
  • 21.Ye Y, Pringle LM, Lau AW, Riquelme DN, Wang H, Jiang T, Lev D, Welman A, Blobel GA, Oliveira AM, Chou MM. TRE17/USP6 oncogene translocated in aneurysmal bone cyst induces matrix metalloproteinase production via activation of NF-kappaB. Oncogene. 2010;29:3619–3629. doi: 10.1038/onc.2010.116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Massague J, Chen YG. Controlling TGF-beta signaling. Genes Dev. 2000;14:627–644. [PubMed] [Google Scholar]
  • 23.Siegel PM, Massague J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer. 2003;3:807–821. doi: 10.1038/nrc1208. [DOI] [PubMed] [Google Scholar]

Articles from International Journal of Clinical and Experimental Pathology are provided here courtesy of e-Century Publishing Corporation

RESOURCES